FF vs NBIX · rev $243.3M vs P/E 45, rev $2.36B
FutureFuel Corp (FF) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
FutureFuel Corp (FF) is a specialty chemicals company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FF revenue for 2024-12-31 was $243.3M. Net income was $15.5M. Revenue was up 164.5% from 2023-12-31 to 2024-12-31. FF currently screens at market cap $185.5M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FF currently screens at market cap $185.5M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FF and NBIX stock pages for the full models.
Not investment advice.